Safety, Tolerability and Pharmacokinetics of MK-4334 in Participants With Alzheimer's Clinical Syndrome on a Stable Dose of Donepezil (MK-4334-005)
Conditions: Alzheimer's Disease; Mild Cognitive Impairment Interventions: Drug: MK-4334; Drug: Placebo to MK-4334; Drug: Donepezil Sponsor: Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials